Beta-lactamase-producing Pseudomonas aeruginosa: Phenotypic characteristics and molecular identification of virulence

Waheed Ullah1, Muhammad Qasim2, Hazir Rahman2

  • 1Department of Biotechnology and Genetic Engineering, Kohat University of Science & Technology, Kohat, Khyber Pakhtunkhwa, Pakistan; Department of Microbiology, Kohat University of Science & Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.

Abstract

Insights

Pseudomonas aeruginosa clinical isolates frequently exhibit biofilm formation and pigment production. These factors, along with various virulence genes, may contribute to the development of drug resistance in these common pathogens.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Pseudomonas aeruginosa is a common cause of infections in immunocompromised individuals and cystic fibrosis patients.
  • Drug resistance and virulence factors are key contributors to P. aeruginosa pathogenicity.

Purpose of the Study:

  • To investigate the prevalence of biofilm formation, pigment production, and specific virulence genes in clinical isolates of P. aeruginosa.
  • To explore the potential link between these factors and the development of drug resistance.

Main Methods:

  • Screening of beta-lactamase-producing P. aeruginosa clinical isolates for biofilm and pigment production.
  • Detection of six key virulence genes (OprI, OprL, LasB, PlcH, ExoS, ToxA) in the isolates.

Main Results:

  • High percentages of isolates showed biofilm formation (85.18%) and pigment production (92.59%).
  • Prevalence of virulence genes varied, with OprI (40.74%), OprL (29.62%), LasB (24%), PlcH (18.5%), ExoS (37.03%), and ToxA (33.33%) detected.
  • A significant proportion (42.59%) of isolates coproduced multiple virulence factors.

Conclusions:

  • Pigment production, biofilm formation, and the presence of virulence genes are common in P. aeruginosa clinical isolates.
  • These identified factors may play a crucial role in the emergence of drug resistance in P. aeruginosa infections.